Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BIOMARIN PHARMACEUTICAL INC | Director | Common Stock | 6.9K | $532K | $77.05 | May 21, 2024 | Direct |
IOVANCE BIOTHERAPEUTICS, INC. | Director | Deferred Restricted Stock Unit | 49.3K | $413K | $8.37 | Jun 11, 2024 | Direct |
Passage BIO, Inc. | Director | Director Stock Option (right to buy) | 47.7K | May 21, 2024 | Direct | ||
Turning Point Therapeutics, Inc. | President & CEO, Director | Common Stock | 0 | $76.00 | Aug 17, 2022 | Direct | |
Turning Point Therapeutics, Inc. | President & CEO, Director | Stock Option (right to buy) | 0 | Aug 17, 2022 | Direct |